Ring in the New Year with Exclusive Discounts from The Business Research Company! Enjoy a 33% markdown on our Opportunities and Strategies Reports and a fantastic 25% off on our Global Market Reports. Don't miss out on this limited-time offer to gain valuable insights and stay ahead in your industry

The Business Research Company’s Respiratory Disease Vaccine Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Respiratory Disease Vaccine Global Market Report 2023 evaluates respiratory disease vaccine market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12924&type=smp

The global respiratory disease vaccine market is expected to grow from $68.4 billion in 2023 to $69.99 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to rising prevalence of respiratory diseases, increased public vaccination awareness, public health initiatives, growing demand for effective and more tolerable vaccines.The respiratory disease vaccine market size is expected to see steady growth in the next few years. It will grow to $76.18 billion in 2028 at a compound annual growth rate (CAGR) of 2.1%.

The increasing incidence of tuberculosis is expected to propel the growth of the respiratory disease vaccine market going forward. Tuberculosis (TB) is a type of respiratory disease caused by the bacterium Mycobacterium tuberculosis, which primarily affects the lungs and potentially impacts other organs and systems in the body, leading to various complications. The increasing incidence of tuberculosis can catalyze efforts to develop and distribute respiratory disease vaccines to reduce the spread of tuberculosis. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population in 2021, an increase of 4.5% from 10.1 million in 2020. Therefore, the increasing incidence of tuberculosis will drive the respiratory disease vaccine market.

Get More Information On The Respiratory Disease Vaccine Market Report:
https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report

The respiratory disease vaccine market segments in the report are:

1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine
2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections
3) By Age: Infant, Adolescent, Adult
4) By End-User: Clinic, Hospital, Other End-Users

Major Players:

Pfizer Inc.
Johnson & Johnson Ltd.
Merck & Co. Inc., Sanofi SA
AstraZeneca PLC
GlaxoSmithKline PLC

The table of contents in TBRC’s Respiratory Disease Vaccine market report includes:

1. Executive Summary
2. Respiratory Disease Vaccine Market Characteristics
3. Respiratory Disease Vaccine Market Trends And Strategies
4. Respiratory Disease Vaccine Market - Macro Economic Scenario
5. Global Respiratory Disease Vaccine Market Size and Growth

.

.

.

26. South America Respiratory Disease Vaccine Market
27. Brazil Respiratory Disease Vaccine Market
28. Middle East Respiratory Disease Vaccine Market
29. Africa Respiratory Disease Vaccine Market
30. Respiratory Disease Vaccine Market Competitive Landscape And Company Profiles


Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model